Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2.
Saved in:
| Title: | Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2. |
|---|---|
| Authors: | Soo JZY; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lim TP; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore; SingHealth Duke-NUS Pathology Academic Clinical Programme, Singapore, Singapore; SingHealth Duke-NUS Medicine Academic Clinical Programme, Singapore, Singapore., Ho JJY; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore., Tong SYC; Victorian Infectious Disease Service, Royal Melbourne Hospital, and University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Lye DC; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; National Centre for Infectious Diseases, Singapore, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Davis JS; Department of Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales, Australia; Menzies School of Health Research, Charles Darwin University, Casuarina, Northern Territory, Australia., Kwa ALH; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore; SingHealth Duke-NUS Medicine Academic Clinical Programme, Singapore, Singapore; Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore. Electronic address: andrea.kwa.l.h@sgh.com.sg. |
| Corporate Authors: | Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA2) Study Group |
| Source: | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2026 May; Vol. 32 (5), pp. 829-837. Date of Electronic Publication: 2026 Feb 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41679464 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Soo+JZY%22">Soo JZY</searchLink>; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+TP%22">Lim TP</searchLink>; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore; SingHealth Duke-NUS Pathology Academic Clinical Programme, Singapore, Singapore; SingHealth Duke-NUS Medicine Academic Clinical Programme, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ho+JJY%22">Ho JJY</searchLink>; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tong+SYC%22">Tong SYC</searchLink>; Victorian Infectious Disease Service, Royal Melbourne Hospital, and University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Lye+DC%22">Lye DC</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; National Centre for Infectious Diseases, Singapore, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Davis+JS%22">Davis JS</searchLink>; Department of Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales, Australia; Menzies School of Health Research, Charles Darwin University, Casuarina, Northern Territory, Australia.<br /><searchLink fieldCode="AU" term="%22Kwa+ALH%22">Kwa ALH</searchLink>; Division of Pharmacy, Singapore General Hospital, Singapore, Singapore; SingHealth Duke-NUS Medicine Academic Clinical Programme, Singapore, Singapore; Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore. Electronic address: andrea.kwa.l.h@sgh.com.sg. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Combination+Antibiotics+for+MEthicillin+Resistant+Staphylococcus+aureus+%28CAMERA2%29+Study+Group%22">Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA2) Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229516420%22">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</searchLink> [Clin Microbiol Infect] 2026 May; Vol. 32 (5), pp. 829-837. <i>Date of Electronic Publication: </i>2026 Feb 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9516420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1469-0691 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221198743X%22">1198743X </searchLink><i>NLM ISO Abbreviation: </i>Clin Microbiol Infect <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41679464 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cmi.2026.01.032 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 829 Titles: – TitleFull: Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Soo JZY – PersonEntity: Name: NameFull: Lim TP – PersonEntity: Name: NameFull: Ho JJY – PersonEntity: Name: NameFull: Tong SYC – PersonEntity: Name: NameFull: Lye DC – PersonEntity: Name: NameFull: Davis JS – PersonEntity: Name: NameFull: Kwa ALH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1469-0691 Numbering: – Type: volume Value: 32 – Type: issue Value: 5 Titles: – TitleFull: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases Type: main |
| ResultId | 1 |
